Immunocompromised Patients With COVID-19 Receive Interferon Gamma
JAMA
.
2021 Dec 14;326(22):2250.
doi: 10.1001/jama.2021.21964.
Author
Jennifer Abbasi
PMID:
34905045
DOI:
10.1001/jama.2021.21964
No abstract available
Publication types
News
MeSH terms
COVID-19 / virology
COVID-19 Drug Treatment*
Humans
Immunocompromised Host*
Interferon-gamma / therapeutic use*
SARS-CoV-2 / isolation & purification
Viral Load / drug effects
Substances
Interferon-gamma